INSM
NASDAQ · Biotechnology
Insmed Inc
$149.86
-1.17 (-0.77%)
Analyst Consensus
Strong Buy
27
Analysts
High
Coverage
Price Target
Analyst Price Target
-4.3% upside
Low Target
$91.17
Average Target
$143.40
High Target
$177.14
Current Price
$149.86
Current
$149.86
$149.86
Target
$143.40
$143.40
$91.17
$143.40 avg
$177.14
Scenario Analysis
Bear Case
$91.17
-39.2%
Low target
Base Case
$143.40
-4.3%
Avg target
Bull Case
$177.14
+18.2%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$212.75
-29.6% from high
52-Week Low
$60.40
+148.1% from low
50-Day SMA
$177.14
-15.4% vs SMA
200-Day SMA
$136.36
+9.9% vs SMA
RSI (14)
37.7
Neutral
Target vs 52W High
$143.40
-32.6% vs high
Next Earnings Report
Feb 19, 2026 · Before Market Open
3d
until earnings
EPS Est: $-1.12
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 37 | 68% | $257.58 | +15.3% |
| AMGN | Hold | 41 | 54% | $190.87 | -50.3% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.8% |
| VRTX | Strong Buy | 39 | 77% | $438.34 | -8.3% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.2% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -68.8% |
| INSM | Strong Buy | 27 | 93% | $143.40 | -4.3% |
| BIIB | Hold | 42 | 48% | $91.45 | -54.5% |